Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients

Bodri, Daniel; Guillén, Juan José; Schwenn, K.; Casadesus, Sara; Vidal, R.; Coll, O.

doi:10.1016/j.fertnstert.2008.07.1762

Cited by 21 publications

(24 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is of particular importance because, although some studies report no association between the difficulty of the ET and the chance of pregnancy, a recent meta‐analysis based on five low‐quality studies has suggested that a difficult ET may be associated with a lower clinical pregnancy rate . The usual quantifiable variables reflecting procedure difficulty are the use of vulsellum, and prolonged manipulation and insertion of the ET catheter . Both of these factors, however, were controlled for in this study.…”

Section: Discussioncontrasting

confidence: 99%

Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles

Saravelos

Wong

Kong

et al. 2016

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 99%

Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles

Saravelos

Wong

Kong

et al. 2016

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…The clinical pregnancy rate varied between 16 and 40% (Supplementary Table 2), like other recipients of donated oocytes (18,217,218,219,220,221,222,223,224,225,226,227). The pooled proportion (random effects model) of clinical pregnancy per embryo transfer was 28% (95% CI 23-34%) ( Supplementary Fig.…”

Section: Assisted Reproductive Technologies With Oocyte Donation (Od)mentioning

confidence: 99%

“…Initial studies found high rates of early pregnancy loss in TS females ranging from 16 to 80% (219, 220,221,222,223,224), likely related to inadequate HRT (228). A structurally abnormal uterus, autoimmune mechanisms and/or diminished endometrial receptivity due to longterm hypoestrogenism may also increase spontaneous abortion rates in women with TS (229).…”

Section: Assisted Reproductive Technologies With Oocyte Donation (Od)mentioning

confidence: 99%

“…In TS, the incidence of hypertensive disorders of pregnancy has been reported to be 35-67% in singleton pregnancies and as high as 100% in multiple pregnancies (222, 224, 225, 226, 231, 232, 233). The reported incidence of pre-eclampsia ranged between 18% and 44% in singleton pregnancies and 75-100% in multiples, while the cesarean section rate is as high as 82-100% (222, 224,225,226,231,232,233). In comparison, in oocyte recipients without TS, the rate of hypertensive disorders of pregnancy is 13-39%, and the cesarean section rate is 31-85% in singleton pregnancies (234).…”

Section: Assisted Reproductive Technologies With Oocyte Donation (Od)mentioning

confidence: 99%

“…Additional studies have estimated the risk of maternal cardiac complications to be 0-4% in OD pregnancies in women with TS (222, 224,225,226,231,232,233). The risk of AoD during a multiple gestation is estimated in the literature to be approximately five times higher than that associated with a singleton pregnancy (232).…”

Section: Cardiovascular Risks During Pregnancymentioning

confidence: 99%

See 2 more Smart Citations

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Gravholt¹,

Andersen

Conway

et al. 2017

European Journal of Endocrinology

909

1,259

View full text Add to dashboard Cite

Turner syndrome affects 25-50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty fields involved in the care of girls and women with TS. This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: 1) diagnostic and genetic issues, 2) growth and development during childhood and adolescence, 3) congenital and acquired cardiovascular disease, 4) transition and adult care, and 5) other comorbidities and neurocognitive issues. These groups produced proposals for the present guidelines. Additionally, four pertinent questions were submitted for formal GRADE (Grading of Recommendations, Assessment, Development and Evaluation) evaluation with a separate systematic review of the literature. These four questions related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy. The guidelines project was initiated by the European Society of Endocrinology and the Pediatric Endocrine Society, in collaboration with the European Society for Paediatric Endocrinology, the Endocrine Society, the European Society of Human Reproduction and Embryology, the American Heart Association, the Society for Endocrinology, and the European Society of Cardiology. The guideline has been formally endorsed by the European Society of Endocrinology, the Pediatric Endocrine Society, the European Society for Paediatric Endocrinology, the European Society of Human Reproduction and Embryology and Summary of recommendationsThe recommendations (R) are worded as recommend (strong recommendation) and suggest (weak recommendation). We formally graded only the evidence underlying recommendations for therapeutic choices. The quality of evidence behind the recommendations is classified as very low (⨁◯◯◯), low (⨁⨁◯◯), moderate (⨁⨁⨁◯) and strong (⨁⨁⨁⨁). See further section 'Summary of methods used for guideline development'. Diagnosis and geneticsR 1.1. We recommend considering a diagnosis of TS in phenotypic females with a karyotype containing one X chromosome and complete or partial absence of the second sex chromosome, associated with one or more typical clinical manifestations of TS (⨁⨁⨁⨁). R 1.2. We recommend against considering a diagnosis of TS in females with one X chromosome and a deletion distal to Xq24 on the other X chromosome, and in women over the age of 50 years with less than 5% 45,X mosaicism (⨁⨁◯◯). R 1.3. We suggest that the new general surveillance management guideline applies to TS patients with any karyotype (⨁⨁◯◯). R 1.4. We recommend to consider testing for Turner syndrome (TS) in a female with typical signs (Table 2) (⨁⨁⨁⨁). R 1.5. We ...

show abstract

Fertility Preservation for Turner Syndrome

2020

View full text Add to dashboard Cite

Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients

Cited by 21 publications

References 21 publications

Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles

Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles

Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting

Fertility Preservation for Turner Syndrome

Contact Info

Product

Resources

About